| Symbol | ICCC |
|---|---|
| Name | IMMUCELL CORP /DE/ |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | In Vitro & In Vivo Diagnostic Substances |
| Address | 56 EVERGREEN DR, PORTLAND, ME 04103 |
| Telephone | 2078782770 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000811641 |
| Description | None |
Director te Boekhorst Paul Francis Olivier 🟢 acquired 8.0K shares of IMMUCELL CORP /DE/ (ICCC) at $9.49 Transaction Date: Jun 18, 2026 | Filing ID: 021258
Read more(99% Positive) IMMUCELL CORP /DE/ (ICCC) Reports Q2 2026 Financial Results
Read moreImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026
Read moreNew Form 10-K/A - IMMUCELL CORP /DE/ <b>Filed:</b> 2026-05-13 <b>AccNo:</b> 0001437749-26-016719 <b>Size:</b> 418 KB
Read moreImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026
Read moreNew Form DEF 14A - IMMUCELL CORP /DE/ <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001437749-26-013234 <b>Size:</b> 2 MB
Read moreNew Form 3 - IMMUCELL CORP /DE/ <b>Filed:</b> 2026-04-23 <b>AccNo:</b> 0001437749-26-013122 <b>Size:</b> 4 KB
Read more